The federal government filed a civil False Claims Act complaint against Regeneron Pharmaceuticals Inc. of Tarrytown, N.Y., alleging that the company paid millions of dollars in kickbacks by using a foundation to cover Medicare beneficiaries’ co-pays for its macular degeneration drug Eylea. “Regeneron funneled tens of millions of dollars in kickbacks through a third-party foun... Read More